Increasing attention is being given to exploring whether fatigue in patients with cancer experiencing similar symptoms can be classified or grouped into specific clinically significant subtypes. Various methods have been used to classify these patients according to subtype, including 1) definitional, 2) severity, 3) qualitative, 4) treatment-related, 5) disease-related, 6) symptom cluster, and 7) putative mechanisms.
The authors wish to acknowledge Dr. Ann M. Berger's review of this manuscript and the unknown individuals who provided blinded reviews. A special thank you to Dr. Pamela S. Hinds, PhD, RN, FAAN, who provided key cancer-related fatigue articles on children, adolescents, and parents experiencing the diagnosis and treatment of cancer; without her help, our “adult slip/pants” might have been showing.
Berger AM, Abernathy AP, Atkinson A et al.. NCCN clinical practice guidelines in oncology: cancer-related fatigue. Version 1, 2010. Available at: http://www.nccn.org/professionala/physician_gls/PDF/fatigue.pdf. Accessed June 1, 2010.
Clinical Care Options. Cancer-related fatigue. Available at: http://www.clinicaloptions.com/inPractice/Oncology/Supportive_Care/ch48_SuppCare-Fatigue.aspx. Accessed February 15, 2010.
Jean-Pierre P, Figueroa-Moseley CD, Kohli S et al.. Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist 2007;12(Suppl 1):11–21.
Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull 2008;134:700–741.
Lynch J, Mead G, Greig C et al.. Fatigue after stroke: the development and evaluation of a case definition. J Psychosom Res 2007;63:539–544.
Cella D, Peterman A, Passik S et al.. Progress toward guidelines for the management of fatigue. Oncology (Williston Park) 1998;12:369–377.
Cella D, Davis K, Breitbart W et al.. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 2001;19:3385–3391.
Sadler IJ, Jacobsen P, Booth-Jones M et al.. Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. J Pain Symptom Manage 2002;23:406–416.
Fernandes R, Stone P, Andrews P et al.. Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: evaluation of diagnostic criteria for cancer-related fatigue. J Pain Symptom Manage 2006;32:245–254.
Murphy H, Alexander S, Stone P. Investigation of diagnostic criteria for cancer-related fatigue syndrome in patients with advanced cancer: a feasibility study. Palliat Med 2006;20:413–418.
Van Belle S, Paridaens R, Evers G et al.. Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool. Support Care Cancer 2005;13:246–254.
Bennett B, Goldstein D, Friedlander M et al.. The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study. J Pain Symptom Manage 2007;34:126–135.
Mendoza TR, Wang XS, Cleeland CS et al.. The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 1999;85:1186–1196.
Meeske K, Smith AW, Alfano CM et al.. Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL study report. Qual Life Res 2007;16:947–960.
Jeon S, Given CW, Sikorskii A, Given B. Do interference-based cut-points differentiate mild, moderate, and severe levels of 16 cancer-related symptoms over time? J Pain Symptom Manage 2009;37:220–232.
Butt Z, Wagner LI, Beaumont JL et al.. Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage 2008;35:20–30.
Cella D, Lai JS, Chang CH et al.. Fatigue in cancer patients compared with fatigue in the general united states population. Cancer 2002;94:528–538.
Hinds PS, Yang Y, Gattuso JS et al.. Psychometric and clinical assessment of the 10-item reduced version of the fatigue scale-child instrument. J Pain Symptom Manage 2010;39:572–578.
Wielgus KK, Berger AM, Hertzog M. Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer. Oncol Nurs Forum 2009;36:38–48.
Doorenbos A, Given B, Given C et al.. Reducing symptom limitations: a cognitive behavioral intervention randomized trial. Psychooncology 2005;14:574–584.
Given B, Given CW, Sikorskii A et al.. Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points? J Pain Symptom Manage 2008;35:126–135.
Revicki D, Hays R, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient reported outcomes. J Clin Epi 2008;61:102–109.
Sloan J, Cella D, Hays R. Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epi 2005;58:1217–1219.
Miaskowski C, Dodd M, West C et al.. The use of a responder analysis to identify differences in patient outcomes following a self-care intervention to improve cancer pain management. Pain 2007;129:55–63.
Miaskowski C, Cooper BA, Paul SM et al.. Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum 2006;33:E79–89.
Teunissen SC, Wesker W, Kruitwagen C et al.. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 2007;34:94–104.
Francoeur RB. The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation. J Pain Symptom Manage 2005;29:130–155.
Bower JE, Ganz PA, Desmond KA et al.. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 2000;18:743–753.
Bower JE, Ganz PA, Aziz N et al.. T-cell homeostasis in breast cancer survivors with persistent fatigue. J Natl Cancer Inst 2003;95:1165–1168.
Collado-Hidalgo A, Bower JE, Ganz PA et al.. Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings. Brain Behav Immun 2008;22:1197–1200.
Richardson A, Ream E, Wilson-Barnett J. Fatigue in patients receiving chemotherapy: patterns of change. Cancer Nurs 1998;21:17–30.
Berger AM. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 1998;25:51–62.
Berger AM, Lockhart K, Agrawal S. Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens. Oncol Nurs Forum 2009;36:563–570.
Dimsdale JE, Ancoli-Israel S, Ayalon L et al.. Taking fatigue seriously, II: variability in fatigue levels in cancer patients. Psychosomatics 2007;48:247–252.
Miaskowski C, Paul SM, Cooper BA et al.. Trajectories of fatigue in men with prostate cancer before, during, and after radiation therapy. J Pain Symptom Manage 2008;35:632–643.
Dhruva A, Dodd M, Paul SM et al.. Trajectories of fatigue in patients with breast cancer before, during, and after radiation therapy. Cancer Nurs 2010;33:201–212.
Given CW, Given B, Azzouz F et al.. Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. J Pain Symptom Manage 2001;21:456–466.
Reyes-Gibby CC, Aday LA, Anderson KO et al.. Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage 2006;32:118–128.
Bower JE. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun 2007;21:863–871.
Hockenberry MJ, Hooke MC, Gregurich MA et al.. Symptom clusters in children and adolescents receiving cisplatin, doxorubicin, or ifosfamide. Oncol Nurs Forum 2010;37:E16–27.
Chiang YC, Yeh CH, Wang KW, Yang CP. The experience of cancer-related fatigue in Taiwanese children. Eur J Cancer Care 2007;18:43–49.
Cleeland CS, Bennett GJ, Dantzer R et al.. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003;97:2919–2925.
Payne J, Piper BF, Rabinowitz I, Zimmerman B. Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study. Oncol Nurs Forum 2006;33:775–783.
Musselman DL, Miller AH, Porter MR et al.. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001;158:1252–1257.
Cleeland CS, Reyes-Gibby CC. When is it justified to treat symptoms? Measuring symptom burden. Oncology (Williston Park) 2002;16(9 Suppl 10):64–70.
Skerman HM, Yates PM, Battistutta D. Multivariate methods to identify cancer-related symptom clusters. Res Nurs Health 2009;32:345–360.
Huang TW, Lin CC. The mediating effects of depression on sleep disturbance and fatigue: symptom clusters in patients with hepatocellular carcinoma. Cancer Nurs 2009;32:398–403.
Beck SL, Dudley WN, Barsevick A. Pain, sleep disturbance, and fatigue in patients with cancer: using a mediation model to test a symptom cluster. Oncol Nurs Forum 2005;32:542.
Barsevick AM, Dudley WN, Beck SL. Cancer-related fatigue, depressive symptoms, and functional status: a mediation model. Nurs Res 2006;55:366–372.
Doorenbos AZ, Verbitsky N, Given B, Given CW. An analytic strategy for modeling multiple-item responses: a breast cancer symptom example. Nurs Res 2005;54:229–234.
Barsevick AM, Whitmer K, Nail LM et al.. Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage 2006;31:85–95.
Hayduk L, Olson K, Quan H et al.. Temporal changes in the causal foundations of palliative care symptoms. Qual Life Res 2010;19:299–306.
Olson K, Hayduk L, Cree M et al.. The changing causal foundations of cancer-related symptom clustering during the final month of palliative care: a longitudinal study. BMC Med Res Methodol 2008;8:1–11.
Pud D, Ben Ami S, Cooper BA et al.. The symptom experience of oncology outpatients has a different impact on quality-of-life outcomes. J Pain Symptom Manage 2008;35:162–170.
Kozachik SL, Bandeen-Roche K. Predictors of patterns of pain, fatigue, and insomnia during the first year after a cancer diagnosis in the elderly. Cancer Nurs 2008;31:334–344.
Dirksen SR, Belyea MJ, Epstein DR. Fatigue-based subgroups of breast cancer survivors with insomnia. Cancer Nurs 2009;32:404–411.
Liu L, Fiorentino L, Natarajan L et al.. Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy. Psychooncology 2009;18:187–194.
Schubert C, Hong S, Natarajan L et al.. The association between fatigue and inflammation marker levels in cancer patients: a quantitative review. Brain Behav Immun 2007:21:413–427.
Aouizerat B, Dodd M, Lee K et al.. Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biol Res Nurs 2009;11:27–41.
Reyes-Gibby CC, Wu X, Spitz M et al.. Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol 2008;9:777–785.
Landmark-Hoyvik H, Reinertsen KV, Loge JH et al.. Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors. Pharmacogenomics J 2009;9:333–340.
Piper BF, Borneman T, Sun VC et al.. Cancer-related fatigue: role of oncology nurses in translating national comprehensive cancer network assessment guidelines into practice. Clin J Oncol Nurs 2008;12(5 Suppl):37–47.
Whitsett SF, Gudmundsdottir M, Davies B et al.. Chemotherapy-related fatigue in childhood cancer: correlates, consequences, and coping strategies. J Pediatr Oncol Nurs 2008;25:86–96.
Sprangers MA, Sloan JA, Veenhoven R et al.. The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet 2009;12:301–311.